Nanalysis Scientific Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA63000Y1034
CAD
0.13
-0.01 (-7.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

73.01 k

Shareholding (Sep 2024)

FII

0.03%

Held by 1 FIIs

DII

99.97%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Risky -

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -56.67%, its profits have risen by 38.2%
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 19 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.54

stock-summary
Return on Equity

-47.81%

stock-summary
Price to Book

1.72

Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Sep 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.21%
0%
-21.21%
6 Months
-31.58%
0%
-31.58%
1 Year
-56.67%
0%
-56.67%
2 Years
-65.79%
0%
-65.79%
3 Years
-79.03%
0%
-79.03%
4 Years
-89.52%
0%
-89.52%
5 Years
-74.0%
0%
-74.0%

Nanalysis Scientific Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
41.57%
EBIT Growth (5y)
-15.59%
EBIT to Interest (avg)
-6.28
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.99
Sales to Capital Employed (avg)
1.06
Tax Ratio
0.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.72
EV to EBIT
-9.81
EV to EBITDA
36.74
EV to Capital Employed
1.28
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.08%
ROE (Latest)
-47.81%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -12.26% vs 51.43% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 6.25% vs 74.60% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.30",
          "val2": "10.60",
          "chgp": "-12.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "0.20",
          "chgp": "-250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-1.60",
          "chgp": "6.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-126.20%",
          "val2": "-96.00%",
          "chgp": "-3.02%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 59.65% vs 14.92% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.05% vs -69.70% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "45.50",
          "val2": "28.50",
          "chgp": "59.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "-8.90",
          "chgp": "113.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.30",
          "val2": "0.30",
          "chgp": "333.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.60",
          "val2": "0.50",
          "chgp": "-1,620.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-13.60",
          "val2": "-16.80",
          "chgp": "19.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-75.70%",
          "val2": "-475.50%",
          "chgp": "39.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
9.30
10.60
-12.26%
Operating Profit (PBDIT) excl Other Income
-0.30
0.20
-250.00%
Interest
0.20
0.30
-33.33%
Exceptional Items
-0.10
-0.10
Consolidate Net Profit
-1.50
-1.60
6.25%
Operating Profit Margin (Excl OI)
-126.20%
-96.00%
-3.02%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -12.26% vs 51.43% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 6.25% vs 74.60% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
45.50
28.50
59.65%
Operating Profit (PBDIT) excl Other Income
1.20
-8.90
113.48%
Interest
1.30
0.30
333.33%
Exceptional Items
-7.60
0.50
-1,620.00%
Consolidate Net Profit
-13.60
-16.80
19.05%
Operating Profit Margin (Excl OI)
-75.70%
-475.50%
39.98%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 59.65% vs 14.92% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 19.05% vs -69.70% in Dec 2023

stock-summaryCompany CV
About Nanalysis Scientific Corp. stock-summary
stock-summary
Nanalysis Scientific Corp.
Pharmaceuticals & Biotechnology
Nanalysis Scientific Corp., formerly Canvass Ventures Ltd., is a Canada-based company that is engaged in the business of developing, manufacturing and selling portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The NMReady-60 is the fully-featured portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The NMReady-60 family of NMR spectrometers are used by chemical professionals in several industries including in oil and gas, chemical, pharma, biotech, food processing and also by the government and university labs.
Company Coordinates stock-summary
Company Details
Bay 1, 4600 - 5th Street NE , CALGARY AB : T2E 7C3
stock-summary
Tel: 1 587 8990513
stock-summary
stock-summary
Registrar Details